Literature DB >> 20717734

Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas.

Ajay V Maker1, Nora Katabi, Mithat Gonen, Ronald P DeMatteo, Michael I D'Angelica, Yuman Fong, William R Jarnagin, Murray F Brennan, Peter J Allen.   

Abstract

INTRODUCTION: There are no reliable markers of dysplasia in patients with incidentally discovered intraductal papillary mucinous neoplasms of the pancreas (IPMN). IPMN dysplasia may be associated with mucin protein (MUC) expression and histopathologic subtype. We hypothesize that MUC expression in cyst fluid and serum can identify lesions with high risk of malignancy.
METHODS: Cyst fluid and serum were collected from 40 patients during pancreatectomy for IPMN between 2005 and 2009. Samples were grouped into low-risk (low-grade or moderate dysplasia, n = 21) and high-risk groups (high-grade dysplasia or carcinoma, n = 19). Mucin expression (MUC1, MUC2, MUC4, and MUC5AC) was assessed utilizing enzyme-linked immunosorbent assays.
RESULTS: MUC2 and MUC4 cyst fluid concentrations were elevated in high-risk versus low-risk groups (10 ± 3.0 ng/ml vs. 4.4 ± 1.2 ng/ml, p = 0.03; 20.6 ± 10.6 ng/ml vs. 4.5 ± 1.4 ng/ml, p = 0.03, respectively). Corresponding serum samples revealed higher levels of MUC5AC in high-risk compared with low-risk patients (19.9 ± 9.3 ng/ml vs. 2.2 ± 1.1 ng/ml, p = 0.04). Histopathologic subtype was significantly associated with grade of dysplasia, and the intestinal subtype displayed increased MUC2 cyst fluid concentrations (13.8 ± 6.5 ng/ml vs. 4.1 ± 0.9 ng/ml, p = 0.02).
CONCLUSIONS: In this study, high-risk IPMN showed elevated cyst fluid concentrations of MUC2 and MUC4, and increased serum levels of MUC5AC. High-risk IPMN also displayed a distinct mucin expression profile in specific histologic subtypes. These data, if validated, may allow surgeons to more appropriately select patients for operative resection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20717734      PMCID: PMC4241376          DOI: 10.1245/s10434-010-1225-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  37 in total

Review 1.  The MUC family: an obituary.

Authors:  Jan Dekker; John W A Rossen; Hans A Büller; Alexandra W C Einerhand
Journal:  Trends Biochem Sci       Date:  2002-03       Impact factor: 13.807

2.  The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas.

Authors:  J Lüttges; B Feyerabend; T Buchelt; M Pacena; G Klöppel
Journal:  Am J Surg Pathol       Date:  2002-04       Impact factor: 6.394

3.  Pancreatic cysts: depiction on single-shot fast spin-echo MR images.

Authors:  Xiao-Ming Zhang; Donald G Mitchell; Masako Dohke; George A Holland; Laurence Parker
Journal:  Radiology       Date:  2002-05       Impact factor: 11.105

Review 4.  Muc4/sialomucin complex in the mammary gland and breast cancer.

Authors:  K L Carraway; S A Price-Schiavi; M Komatsu; S Jepson; A Perez; C A Carraway
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

5.  New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.

Authors:  Akiko Nakamura; Michiko Horinouchi; Masamichi Goto; Kohji Nagata; Koro Sakoda; Sonshin Takao; Kohzoh Imai; Young S Kim; Eiichi Sato; Suguru Yonezawa
Journal:  J Pathol       Date:  2002-06       Impact factor: 7.996

6.  Cytology from pancreatic cysts has marginal utility in surgical decision-making.

Authors:  Ajay V Maker; Linda S Lee; Chandrajit P Raut; Thomas E Clancy; Richard S Swanson
Journal:  Ann Surg Oncol       Date:  2008-09-03       Impact factor: 5.344

7.  The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.

Authors:  Suguru Yonezawa; Akiko Nakamura; Michiko Horinouchi; Eiichi Sato
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

8.  Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.

Authors:  Benoît Terris; Sylvie Dubois; Marie-Pierre Buisine; Alain Sauvanet; Philippe Ruszniewski; Jean-Pierre Aubert; Nicole Porchet; Anne Couvelard; Claude Degott; Jean-Francois Fléjou
Journal:  J Pathol       Date:  2002-08       Impact factor: 7.996

Review 9.  Mucin expression profile in pancreatic cancer and the precursor lesions.

Authors:  Kohji Nagata; Michiko Horinouchi; Miyuki Saitou; Michiyo Higashi; Mitsuharu Nomoto; Masamichi Goto; Suguru Yonezawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-05-29

Review 10.  Altered mucin expression in the gastrointestinal tract: a review.

Authors:  J R Jass; M D Walsh
Journal:  J Cell Mol Med       Date:  2001 Jul-Sep       Impact factor: 5.310

View more
  44 in total

1.  Circulating Leptin and Branched Chain Amino Acids-Correlation with Intraductal Papillary Mucinous Neoplasm Dysplastic Grade.

Authors:  Michele T Yip-Schneider; Rachel Simpson; Rosalie A Carr; Huangbing Wu; Hao Fan; Ziyue Liu; Murray Korc; Jianjun Zhang; C Max Schmidt
Journal:  J Gastrointest Surg       Date:  2018-09-13       Impact factor: 3.452

Review 2.  Novel Biomarkers for Pancreatic Cysts.

Authors:  Harkirat Singh; Kevin McGrath; Aatur D Singhi
Journal:  Dig Dis Sci       Date:  2017-02-14       Impact factor: 3.199

Review 3.  Molecular Diagnostics and Testing for Pancreatic Cysts.

Authors:  Jaime de la Fuente; Shounak Majumder
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-27

4.  Prostaglandin E2: A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia.

Authors:  Michele T Yip-Schneider; Rosalie A Carr; Huangbing Wu; C Max Schmidt
Journal:  J Am Coll Surg       Date:  2017-07-21       Impact factor: 6.113

Review 5.  The diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas: has progress been made?

Authors:  Jenny Lim; Peter J Allen
Journal:  Updates Surg       Date:  2019-06-07

6.  Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Authors:  Mohammad A Al Efishat; Marc A Attiyeh; Anne A Eaton; Mithat Gönen; Denise Prosser; Anna E Lokshin; Carlos Fernández-Del Castillo; Keith D Lillemoe; Cristina R Ferrone; Ilaria Pergolini; Mari Mino-Kenudson; Neda Rezaee; Marco Dal Molin; Matthew J Weiss; John L Cameron; Ralph H Hruban; Michael I D'Angelica; T Peter Kingham; Ronald P DeMatteo; William R Jarnagin; Christopher L Wolfgang; Peter J Allen
Journal:  Ann Surg       Date:  2018-08       Impact factor: 12.969

7.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

Review 8.  Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Kiara A Tulla; Ajay V Maker
Journal:  Langenbecks Arch Surg       Date:  2017-12-07       Impact factor: 3.445

9.  Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.

Authors:  Albert Strauss; Matthew Birdsey; Stefan Fritz; Bogata D Schwarz-Bundy; Frank Bergmann; Thilo Hackert; Hans-Ullrich Kauczor; Lars Grenacher; Miriam Klauss
Journal:  Br J Radiol       Date:  2016-03-09       Impact factor: 3.039

10.  Interobserver variability in intraductal papillary mucinous neoplasm subtypes and application of their mucin immunoprofiles.

Authors:  Heewon A Kwak; Xiuli Liu; Daniela S Allende; Rish K Pai; John Hart; Shu-Yuan Xiao
Journal:  Mod Pathol       Date:  2016-05-20       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.